Tim Smith

Children at risk for developing asthma may see benefits from a new screening tool developed to detect symptoms in children age 3 and up.

A research team described data regarding the potential of escalating adalimumab doses for certain patients with psoriasis.

A recent study found that worsened visual acuity and depression were associated with neurobiological changes visible through MRI scans.

A combination therapy approach may be useful for psoriasis treatment, though an 8-week regimen may not be long enough.

A discussion with Dr. Lal on the successful trials and recent approval of dupilumab as a treatment for skin inflammation.

Data indicates a greater number of physicians is a better predictor of melanoma diagnoses than UV radiation rates.

A study finds delayed puberty, a comorbidity of epidermolysis bullosa, may affect skeletal health.

The FDA recently approved a drug treatment for prurigo nodularis, studied across over 60 clinical trials.

A review examined the ways in which costs can be reduced for patients with varying types of atopic dermatitis.

A discussion on the positive outcomes of acupuncture for Parkinson’s patients struggling with the effects of anxiety.

Research suggests that tildrakizumab may be useful in real-life settings against moderate-to-severe plaque psoriasis.

A discussion was held regarding research on the use of antivirals on younger influenza patients.

Research has highlighted new information for the identification of risk factors for dementia.

Research finds potential benefits to using apremilast for plaque psoriasis patients.

A study from the Netherlands suggests steps to address patients’ sleep health.

A study in China found that Parkinson’s patients treated with acupuncture saw reduced anxiety levels.

A discussion on research into allergic contact dermatitis and its connection to allergens in skincare products.

Officials with the US Preventive Services Task Force have new recommendations for adult mental health screens.

A recent study in China aligns with findings regarding lower life quality rankings for older adults.

The results of two phase 3 clinical trials suggest a topical psoriasis treatment option.

Research upholds prior recommendations for treating younger patients hospitalized with influenza.

New findings illuminate the need for clinicians to address sleep issues for patients with autism.

A discussion on the recent success of phase 3 trials regarding chronic sinusitis and nasal polyp treatment.

French researchers find that targeted allergy assessments may be needed in children with peanut allergies.

There is a high risk for contact dermatitis in retail products for skincare, due to the prevalence of allergens.

Due to the lack of a standard set of ‘good sleep’ criteria, a questionnaire was developed to help gauge criteria for sleep health.

Research shown at EADV 2022 demonstrated the efficacy of an antibody designed to protect against inflammatory skin disorders.

Research from a double-blind trial suggests a lack of need for clinicians to implement glutamine therapy for burn victims.

New research presented at EADV 2022 suggests positive results for a new JAK1-selective inhibitor for hidradenitis suppurativa.

Dr. Reid Robison, MD, MBA, described his research on clinical depression and the recent acceptance of psychedelic medicine.